Hey guys, welcome back to Skin Anarchy. This is EXA and I have such a wonderful brand that I'm going to introduce you guys to today.

And obviously we have the CEO, the mastermind behind it. But, you know, I just want to let everybody know that this conversation is going to be a lot about a topic that I think is now up and coming in the science of skin space, you know, which is this idea of inflammation

and what that really actually means for skin health. So I'm really excited to talk about that

with you guys. Without further ado, please welcome Joshua Britton, who's the CEO of Dende. Welcome,

Josh. I'm so excited to host you. I am so excited to be here. Thanks for having me.

And yeah, really excited to get into the science today behind Dende and what makes us so special.

So thanks for having me.

Yeah, let's go.

Yeah, no, I'd love to dive in.

I know that you're also, you know, behind Debutte, which is a bigger company.

And I'd love to learn a little bit about you, if you don't mind

about, you know, where Dende really started and where the idea came from to focus on, like,

inflammation when it comes to skin health. If you could kind of look at that. Yeah, that's a great one.

Yeah. So, you know, I transitioned out of academia to building a debut and, of course, Dende.

And the real reason behind that is, as you know, most science stays in the lab, right?

I think many people listening to this, many of the people and part of the team have worked on science for many, many, many years.

But it never makes its way out of the lab, into product, into people's homes and makes an impact.

So really start a debut with that.

And of course, the way we actually deliver the best science and the best formulations to the world is through Dende.

And like, Dende has a team now of 80 scientists dedicated to researching and creating novel ingredients through biotechnology.

And yeah, Dende was the thinking of how can we best and quickest bring these benefits to consumers that are truly effective and accessible to all.

And so, you know, we have this platform where we can screen 50 billion molecules to look at consumer needs.

...